Short answer: Aspartimide formation is a base-catalyzed side reaction in which an aspartic acid (Asp) residue cyclizes into a five-membered succinimide ring during solid-phase peptide synthesis (SPPS) [1]. It is triggered mainly during the repeated piperidine treatments used to remove the Fmoc group, and a 2025 review calls it a side reaction that "remains a persistent challenge" and "continues to hinder the synthesis of extended peptide sequences" by the almost universally used Fmoc chemistry [1]. The trouble is not just a lost residue: opening the ring again produces a mixture of normal (α) and rearranged (β) peptides along with the wrong-handed (D) stereoisomer, all of which are hard to separate [1].
This article is educational synthetic and analytical chemistry for laboratory readers. It does not describe effects in people or animals and is not guidance for human or animal use.
What aspartimide is
An aspartimide (abbreviated Asi), also written as a 3-amino-N-alkyl-succinimide, is the cyclic imide formed when an aspartic acid side chain closes onto the peptide backbone [3]. In Fmoc-based peptide synthesis the side-chain carboxyl of Asp is normally masked as an ester — most often the tert-butyl ester, Asp(OtBu) [1]. During the basic Fmoc-removal step the backbone amide nitrogen of the residue just after Asp is deprotonated, and that nitrogen attacks the side-chain ester carbonyl, expelling the protecting group and closing a five-membered ring [1].
The reaction has a long history. The 2025 review by Kong, van den Braak and Neumann traces the first observation of an aspartimide-type product back to Piutti in 1888, well before modern peptide chemistry existed [1]. Today it is "typically encountered during standard Fmoc-deprotection by treatment with 20% piperidine in DMF" [1].
Why it matters: the byproducts are worse than a simple deletion
The succinimide ring is not stable or inert. Once formed it is re-opened by water or by the base itself, and because the ring is symmetric it can open on either side [1]:
- α- and β-peptides. Reopening gives both the normal α-linked peptide and a rearranged β-aspartyl peptide, in which the backbone now runs through the side chain [1].
- Racemization. The reversible rehydration of the imide scrambles the stereocenter, producing the D-form alongside the L-form — the same kind of unwanted chirality change covered in our racemization guide [1][4].
- Base adducts. Piperidine (or another nucleophilic base) can add directly to the imide, giving α- and β-piperidides [1].
It is strongly sequence-dependent
Whether aspartimide forms depends heavily on which residue follows the Asp. The review explains that the propensity "depends on the nature of the C-terminal amino acid residue linked to Asp, whose backbone amide nitrogen acts as the nucleophile," and that it is "especially prevalent in Asp-Gly motifs, likely because Gly is the least sterically hindered residue" [1]. For that reason, model peptides built to study the problem usually contain the Asp-Gly motif — the scorpion-toxin-II fragment Val-Lys-Asp-Gly-Tyr-Ile is a classic test sequence [1].
Glycine is the worst, but it is not the only offender. Summarizing the literature, the review lists Ala, Ser, Thr, Cys, Arg, Asp and Asn as residues that, when they follow Asp, also give especially aspartimide-prone motifs [1]. A systematic study by Mergler and co-workers on the model peptide H-Val-Lys-Asp-Xaa-Tyr-Ile-OH found "considerable amounts of by-products" when Xaa was Asp(OtBu), Arg(Pbf), Asn(Mtt), Cys(Acm) or unprotected Thr [2].
Conditions matter too. The review notes that beyond the sequence, "peptide conformation, solvent, temperature, and the base used for Fmoc-deprotection also significantly influence the extent of this side reaction," with higher solvent polarity leading to more aspartimide [1].
The link to diketopiperazine and chain termination
Aspartimide does not only corrupt a residue — it can also stop a chain. Samson and co-workers reported in 2019 that the Asp-containing intermediate can go on to form an N-terminal diketopiperazine (a piperazine-2,5-dione), which terminates the growing chain [8]. Using NMR they showed that "exclusively the six-membered ring is formed," and crucially that the termination "is directly related to the Asi intermediate," so that "hindering or avoiding Asi formation reduces or completely suppresses this side reaction" [8]. That ties aspartimide directly to the diketopiperazine fragmentation we covered separately, and it means the same preventive measures help with both.
How chemists suppress it
Because aspartimide is base-catalyzed and sequence-driven, prevention works on several fronts. The strategies below are all drawn from the peer-reviewed literature.
Bulkier and smarter side-chain esters
The standard Asp(OtBu) ester is only modestly hindered, so a long line of bulkier esters has been developed to physically block the backbone nitrogen from reaching the carbonyl [1]. Karlström and Undén showed as early as 1996 that "bulky, acyclic, aliphatic protecting groups (in particular the 2,4-dimethyl-3-pentyl ester) are significantly more resistant to base-catalyzed aspartimide formation" than rigid cyclic esters [9]. The 3-methyl-3-pentyl ester, Asp(OMpe), became one of the most widely used of these and remains a common choice [1][2]. More recent trialkyl-carbinol esters push this further: Behrendt and co-workers reported "almost complete reduction of aspartimide formation with accompanied suppression of aspartic acid epimerisation" and applied them to difficult sequences [6].
An important caveat from the review: more steric bulk is not a guarantee. Trityl and ortho-ester protecting groups can actually promote aspartimide, even though they help against other cyclizations [1].
Non-ester masking and backbone protection
The only approaches shown to fully eliminate aspartimide are those that remove the vulnerable ester or block the backbone nitrogen entirely [1]. Two examples:
- Backbone protection. Putting a removable group (such as Hmb) on the backbone amide of the residue after Asp masks the nucleophile that drives the reaction. The review notes that for one model peptide, synthesis without backbone protection gave only about 30% of the desired peptide, whereas using Hmb raised the yield to about 90% [1]. Pseudoprolines, formed from Ser, Thr or Cys, work similarly [1].
- Non-ester side-chain masks. Neumann and co-workers introduced cyanosulfurylides, which "mask carboxylic acids by a stable C-C bond"; these groups are "exceptionally stable to all common manipulations" and are removed under aqueous conditions with an electrophilic halogenating agent [7]. They used the strategy to assemble several demanding peptide and protein targets [7].
Milder deprotection: additives and alternative bases
If the base step is the trigger, tuning it helps:
- Acidic additives. Adding HOBt to the deprotection mixture reduces both aspartimide and the Asp racemization that follows [4]. Michels and co-workers showed that simply adding small amounts of organic acids to piperidine "efficiently prevents formation of aspartimide side products," an effect that was "virtually independent of the acid strength" [5].
- Alternative bases. The highly basic DBU speeds Fmoc removal but makes aspartimide worse [1]. Switching the base can help instead: Palasek and co-workers found piperazine in place of piperidine cut aspartimide and the associated racemization in microwave SPPS [4], and the review reports that about 50% morpholine in DMF gave only ~1.2% aspartimide at room temperature versus ~9.2% for piperidine on a standard model peptide [1]. Personne and co-workers reported dipropylamine as an inexpensive, low-odor deprotection reagent that "strongly reduce[s] aspartimide formation compared to piperidine" at elevated temperature [10].
- Avoiding strong base altogether. Some groups replace the Fmoc group with Nα-protecting groups removed under non-basic conditions (for example pNZ, cleaved with tin(II) chloride), so the base-driven step never happens [1].
Aspartimide beyond the synthesizer
The same ring forms outside the lab. A 2025 review in Chemical Science notes that aspartimide is the key intermediate in the spontaneous chemistry of Asp and Asn residues: it is "involved in the ageing of proteins in vivo" and in their stability in vitro, and can also appear during native chemical ligation, where aspartimide has been observed under forcing conditions of elevated pH and temperature [1][3]. This is the same succinimide intermediate that drives deamidation of asparagine and the isomerization of aspartate — a reminder that aspartimide chemistry is a property of the Asp/Asn side chain itself, not just an artifact of synthesis [3].
Aspartimide vs related terms
- Aspartimide vs racemization: racemization is the loss of stereochemistry in general; aspartimide is one specific route that causes racemization at Asp, because re-opening the imide scrambles the stereocenter [1][4].
- Aspartimide vs diketopiperazine: both are cyclization side reactions, but aspartimide is a five-membered ring on the Asp side chain, while the diketopiperazine is a six-membered ring that leaves the N-terminus; the aspartimide intermediate can lead on to the chain-terminating diketopiperazine [1][8].
- Aspartimide vs deamidation: deamidation of asparagine proceeds through a succinimide (aspartimide) intermediate, so they are two views of the same core chemistry [3].
Frequently asked questions
What is aspartimide in simple terms?
It is a small ring (a succinimide) that an aspartic acid residue forms on itself during peptide synthesis, closing between the side chain and the backbone [1][3].
When does aspartimide form during Fmoc SPPS?
Most often during the basic Fmoc-deprotection step, classically 20% piperidine in DMF, repeated at every cycle [1].
Which sequence is the worst for aspartimide?
Asp-Gly is the most prone, because glycine is the least sterically hindered residue following the Asp; Ala, Ser, Thr, Cys, Arg, Asp and Asn after Asp are also high-risk [1].
Why is aspartimide worse than losing one residue?
Because re-opening the ring gives a mix of α- and β-peptides plus the D-stereoisomer, and the base can also add to the ring — several hard-to-separate impurities from one event, with the β-aspartyl forms often outnumbering the normal one about 3:1 [1].
How do chemists prevent aspartimide?
With bulkier side-chain esters such as Asp(OMpe), backbone or non-ester masking that fully blocks the reaction, acidic additives like HOBt, and milder bases such as piperazine, morpholine or dipropylamine in place of piperidine [1][4][5][7][10].
Bottom line
Aspartimide formation is the classic base-catalyzed side reaction of aspartic acid in Fmoc SPPS: the backbone nitrogen after Asp closes a five-membered ring, which then re-opens into a tangle of α-, β- and D-peptides and base adducts [1]. It is strongly sequence-dependent — worst at Asp-Gly — and it feeds the diketopiperazine chain-termination pathway as well [1][8]. Decades of work have given chemists a full toolbox: bulkier esters, backbone and non-ester masking that can eliminate it outright, acidic additives, and gentler bases [1][4][5][6][7][9][10]. Knowing which lever to pull for a given sequence is what keeps a troublesome Asp from quietly wrecking a synthesis.
All products are for research use only — not for human or animal consumption.